Health needs of HIV-infected women in the United States: Insights from the women living positive survey

AIDS Patient Care and STDs

Volumn 25, Issue 5, 2011, Pages 279-285

  Squires, Kathleen E ^a   Hodder, Sally L ^b   Feinberg, Judith ^c   Bridge, Dawn Averitt ^d   Abrams, Staats ^e   Storfer, Stephen P ^f   Aberg, Judith A ^g  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d Well Project   (United States)

^e GfK Custom Research North America   (United States)

^f BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^g BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE; CONTROLLED STUDY; ETHNICITY; FEMALE; HEALTH CARE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTROSPECTION; MAJOR CLINICAL STUDY; PREGNANCY; UNITED STATES; WOMEN LIVING POSITIVE SURVEY;

ADULT; AGED; ANTI-RETROVIRAL AGENTS; COMMUNICATION; COUNSELING; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INTERVIEWS AS TOPIC; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; UNITED STATES; YOUNG ADULT;

EID: 79955780208     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2010.0228     Document Type: Article

References (29)

1. UNAIDS. Worldwide HIV and AIDS Statistics. 2009. www.avert.org/ worldstats.htm (Last accessed February 28, 2011).
2. HIV prevalence estimates-United States, 2006. MMWR Morb Mortal Wkly Rep 2008;57:1073-1076.
3. Update: AIDS among women-United States, 1994. MMWR Morb Mortal Wkly Rep 1995;44:81-84.
4. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1- infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002;29:484-494. (Pubitemid 34456340)
5. Finocchario-Kessler S, Dariotis JK, Sweat MD, et al. Do HIVinfected women want to discuss reproductive plans with providers, and are those conversations occurring? AIDS Patient Care STDs 2010;24:317-323.
6. Mirochnick M, Best BM, Stek AM, et al. Lopinavir exposure with an increased dose during pregnancy. J Acquir Immune Defic Syndr 2008;49:485-491.
7. Ripamonti D, Cattaneo D, Maggiolo F, et al. Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer. AIDS 2007;21:2409-2415. (Pubitemid 350145172)
8. Hirt D, Urien S, Ekouevi DK, et al. Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109). Clin Pharmacol Ther 2009;85: 182-189.
9. Squires K, Olmscheid B, Guyer B, Zhang S. TDF-containing antiretroviral regimens in pregnancy: Findings from the Antiretroviral Pregnancy Registry. In: 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2009. San Francisco: September 12-15, 2009.
10. Marlink R, Kao H, Hsieh E. Clinical care issues for women living with HIV and AIDS in the United States. AIDS Res Hum Retroviruses 2001;17:1-33. (Pubitemid 32096423)
11. Sowell RL, Seals B, Moneyham L, Guillory J, Demi A, Cohen L. Barriers to health-seeking behaviors for women infected with HIV. Nursingconnections 1996;9:5-17.
12. Squires KE. Gender differences in the diagnosis and treatment of HIV. Gend Med 2007;4:294-307.
13. Hader SL, Smith DK, Moore JS, Holmberg SD. HIV infection in women in the United States: Status at the Millennium. JAMA 2001;285:1186-1192. (Pubitemid 32198485)
14. Merck & Co, Inc ISENTRESS ® (raltegravir) [full prescribing information]. www.merck.com/product/usa/pi-circulars/ i/isentress/isentress-pi. pdf (Last accessed April 22, 2010).
15. Pfizer Labs SELZENTRY ® (maraviroc) tablets [full prescribing information]. http://us.gsk.com/products/assets/ us-selzentry.pdf (Last accessed April 22, 2010).
16. Boehringer Ingelheim Pharmaceuticals, Inc APTIVUS ® (tipranavir) capsules and oral solution [full prescribing information]. http://bidocs. boehringer-ingelheim.com/BIWebAccess/ ViewServlet.ser?docBase = renetnt&folderPath = /Prescribing + Information/PIs/Aptivus/10003515 +US+ 01.pdf (Last accessed April 22, 2010).
17. Tibotec Therapeutics INTELENCE ® (etravirine) tablets [full prescribing information]. www.intelence-info.com/ intelence/assets/pdf/ INTELENCE-PI.pdf Accessed 22 April 2010
18. Tibotec Therapeutics PREZISTA ® (darunavir) tablet, film coated for oral use [full prescribing information]. http:// www.prezista.com/prezista/ documents/us-package-insert .pdf Accessed 22 April 2010
19. Molina JM, Andrade-Villanueva J, Echevarria J, et al. Oncedaily atazanavir/ritonavir compared with twice-daily lopinavir/ ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV- 1-infected patients: 96-week efficacy and safety results of the CASTLE study. J Acquir Immune Defic Syndr 2008;53: 323-332.
20. Smith KY, Patel P, Fine D, et al. Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment. AIDS 2009;23:1547-1556.
21. Cotton DJ, Finkelstein DM, He W, Feinberg J. Determinants of accrual of women to a large, multicenter clinical trials program of human immunodeficiency virus infection. The AIDS Clinical Trials Group. J Acquir Immune Defic Syndr 1993;6:1322-1328.
22. Currier J, Averitt Bridge D, Hagins D, et al. Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial. Ann Intern Med 2010;153:349-357.
23. Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA 2001;285:1466-1474. (Pubitemid 32221895)
24. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998;9:117-125. (Pubitemid 28157608)
25. Moneyham L, Murdaugh C, Phillips K, et al. Patterns of risk of depressive symptoms among HIV-positive women in the southeastern United States. J Assoc Nurses AIDS Care 2005; 16:25-38. (Pubitemid 41265204)
26. Kempf MC, McLeod J, Boehme AK, et al. A qualitative study of the barriers and facilitators to retention-in-care among HIV-positive women in the rural southeastern United States: Implications for targeted interventions. AIDS Patient Care STDs 2010;24:515-520.
27. Vyavaharkar M, Moneyham L, Corwin S, Saunders R, Annang L, Tavakoli A. Relationships between stigma, social support, and depression in HIV-infected African American women living in the rural Southeastern United States. J Assoc Nurses AIDS Care 2010;21:144-152.
28. Sowell RL, Seals BF, Moneyham L, Demi A, Cohen L, Brake S. Quality of life in HIV-infected women in the south-eastern United States. AIDS Care 1997;9:501-512. (Pubitemid 27462301)
29. Vyavaharkar M, Moneyham L, Tavakoli A, et al. Social support, coping, and medication adherence among HIVpositive women with depression living in rural areas of the southeastern United States. AIDS Patient Care STDS 2007; 21:667-680. (Pubitemid 47525390)